Recurrent Mycosis Fungoides Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Mycosis fungoides recurrent

IndicationStatusPhase
DBCOND0080283 (Recurrent Mycosis Fungoides)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03075553Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell LymphomaTreatment